Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Journal of Computer-Aided Molecular Design|June 18, 2017
GalaxyDock BP2 score: a hybrid scoring function for accurate protein-ligand dockingMinkyung Baek, Woong-Hee Shin, Hwan Won Chung, et al.Journal of Molecular Modeling|February 8, 2008
Hologram and 3D-quantitative structure toxicity relationship studies of azo dyesF A Pasha, Muhammad Muddassar, Hwan Won Chung, et al.Journal of Computer-Aided Molecular Design|April 2, 2010
QM/MM based 3D QSAR models for potent B-Raf inhibitorsJae Yoon Chung, Hwan Won Chung, Seung Joo Cho, et al.Journal of Microbiology (Seoul, Korea)|March 12, 2010
Designing primers from multiple sequences using Matchup program to improve detection of hepatitis B virus by polymerase chain reactionSo Young Jang, Mi Suk Kim, Min Seok Park, et al.Bioorganic & Medicinal Chemistry Letters|February 5, 2024
Identification of 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one scaffolds as potent Lck inhibitors as anti-cancer agentsSu Hyun Ji, Han Byeol Kim, Yeonju Song, et al.Chemical Biology & Drug Design|April 18, 2023
Identification of novel class inhibitors of NSD3 methyltransferase showing a unique, bivalent binding mode in the SET domainSumin Kim, Injeoung Hwang, Suhn Hyung Kim, et al.European Journal of Medicinal Chemistry|December 7, 2023
Identification of a novel potent CDK inhibitor degrading cyclinK with a superb activity to reverse trastuzumab-resistance in HER2-positive breast cancer in vivoRatnakar Reddy Kuchukulla, Injeoung Hwang, Suhn Hyung Kim, et al.Pharmaceuticals (Basel, Switzerland)|September 23, 2022
Novel 2,6,9-Trisubstituted Purines as Potent CDK Inhibitors Alleviating Trastuzumab-Resistance of HER2-Positive Breast CancersRatnakar Reddy Kuchukulla, Injeoung Hwang, Sang Won Park, et al.Bioorganic & Medicinal Chemistry|March 9, 2024
Discovery of N-benzylbenzamide-based allosteric inhibitors of Aurora kinase AHyomin Lee, Euijung Kim, Narae Hwang, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|September 7, 2022
Identification of novel pyrrolopyrimidine and pyrrolopyridine derivatives as potent ENPP1 inhibitorsHee Jin Jeong, Hye Lim Lee, Sung Joon Kim, et al.Pageof 2